LYOPHILIZED FORMULATION

LYOPHILIZED FORMULATION

For clinical application of cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(R1)]platinum(II) (R1 is an alkanoyloxy group having 6 to 20 carbon atoms), the present invention aims at providing a formulation which prevents layer separation and changes in viscosity, shows fine suspendability, and whic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: MIZUNO KIMIHIRO
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:For clinical application of cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(R1)]platinum(II) (R1 is an alkanoyloxy group having 6 to 20 carbon atoms), the present invention aims at providing a formulation which prevents layer separation and changes in viscosity, shows fine suspendability, and which is easy to handle during administration. The formulation of the present invention is a lyophilized a formulation for injection obtained by dissolving a cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(R1)]platinum(II) in 2-methyl-2-propanol and lyophilizing this solution, which has a central particle size distribution of around 3-25 mum and a D90% value of not more than 40 mum.